Reliant Pharmaceuticals, Inc. Sets IPO at 11.7 Million Shares, $25-$27

WASHINGTON, Oct 24 (Reuters) - Reliant Pharmaceuticals Inc on Wednesday set its planned initial public offering at 11.72 million shares for an estimated price of $25 to $27 each.

MORE ON THIS TOPIC